undamentalytics Newsletter
Sign in

Imax Corp (IMAX) stock

Add to watchlist

Add holding +

NYSE: IMAX NYSE Movies & Entertainment Next results ~November 5, 2026

Imax Corp is a US-listed company in the movies & entertainment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$48

Forward price-to-earnings vs peers

Base case. Range ~$35–$86. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.

Price vs value

No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Imax Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 9 selling0 purchases and 28 sales by directors and officers, last 12 monthsInsider trades
  • Funds131 adding, 109 cuttingOf 45 active managers that changed their stake, 20 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 59% in the quarter to 2026-06-30, the 4th beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 10.7% over 90 days.

Things to watch

  • Insiders selling. 9 insiders sold $70M of stock over the past 365 days and none bought (65% under pre-set trading plans).
  • Heavily shorted. 19.1% of the shares available to trade are sold short (6.6 days of average volume to cover).

Latest results

Earnings per share
$0.43 against an average estimate of $0.27: beat by 58.8%
Share reaction
+10.4% in the first session after the results on July 23, 2026, against -1.1% for the S&P 500
Next report
November 5, 2026; average EPS estimate $1.03

Imax's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.3%
  • 1 week-3.9%
  • 1 month-4.3%
  • This year+34.7%
  • 1 year+54.6%
  • 5 years+156.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Earnings

Last results
July 23, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Insider trade
  3. Insider trade
  4. Leadership
  5. Insider trade
  6. Insider trade
  7. Insider trade
  8. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Imax Corp valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation models

We value Imax Corp as an operating company, with every model that fits that kind of business. Cost of equity 7.7%: the 10-year Treasury yield (4.9%) plus a beta of 0.6 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: no revenue, margin or share count to start from
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$48 ~$35–$86 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: no twelve-month earnings or share count in the filings yet
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: no twelve-month earnings or share count in the filings yet
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. — 0 Does not apply: no positive value
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$48 ~$35–$86 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Imax Corp with Movies & Entertainment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, before the open. Analysts expect revenue of $168m and EPS of $1.03 (range $0.82 to $1.21) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $2.23 +54% $484m +18%
Next $2.27 +2% $494m +2%

Next year's EPS estimate has moved +10.7% in 90 days, across 9 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +22.4% on 90 days ago. In the last 30 days, 3 analysts raised Imax Corp's forecast and 0 cut it.

Consensus EPS forecast Imax Corp, last 90 days
$1.80 $2.00 $2.20 $2.40 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.82 Current fiscal year, 60 days ago: $1.84 Current fiscal year, 30 days ago: $1.92 Current fiscal year, 7 days ago: $2.13 Current fiscal year, Now: $2.23 $2.23 Next fiscal year, 90 days ago: $2.05 Next fiscal year, 60 days ago: $2.07 Next fiscal year, 30 days ago: $2.10 Next fiscal year, 7 days ago: $2.23 Next fiscal year, Now: $2.27 $2.27

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.82$2.05
60 days ago $1.84$2.07
30 days ago $1.92$2.10
7 days ago $2.13$2.23
Now $2.23$2.27

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.27 $0.43 +58.8%
Mar 2026 $0.15 $0.17 +10.8%
Dec 2025 $0.47 $0.58 +22.9%
Sept 2025 $0.39 $0.47 +20.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

12 analysts, Oct 2026
Buy1083%
Hold217%
Sell00%

Monthly trend

  1. Oct 202637212
  2. Sep 202637212
  3. Aug 202627211
  4. Jul 202627211

Counts of recommendations published by analysts covering Imax Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
19.1%
of tradable shares
Days to cover
6.61
at average volume
Short interest, 1 month
+5%
to October 15, 2026
Held by institutions
99%
of shares
Held by insiders
17.9%
of shares
Employees
679
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
IMAX−1%−18%+3%+70%+44%+35%
Industry peers (median)−7%−43%+7%+24%+5%+10%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
IMAX50%25%58%58%58%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
IMAX−44%−42%−29%−15%−22%−23%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 82% from December 16, 2015 to March 17, 2020. Getting back needed a 453% gain, reached on February 26, 2026, 2172 days after the low.

Price behaviour

52-week range
$32.53 – $56.33
From 52-week high
−11.6%
vs 50-day average
−5.0%
vs 200-day average
+16.0%
Volatility (1 year)
44%
Beta vs S&P 500
0.13

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±6.6%
After a week
7 up, 5 down
typical move ±9.3%
After a month
8 up, 4 down
typical move ±11.9%
Results releasedNext dayS&P 500 next day5 days21 days
July 23, 2026 +10.4% −1.1% +21.1% +34.2%
April 30, 2026 −2.0% +1.3% −4.3% +8.7%
February 25, 2026 +13.4% +0.3% +11.8% +2.5%
October 23, 2025 −1.1% +1.4% +1.2% +12.4%
July 24, 2025 −7.5% +0.5% −11.2% −6.8%
April 23, 2025 −0.9% +3.7% +3.5% +14.5%
February 19, 2025 −0.3% −0.2% −4.8% −2.0%
October 30, 2024 +15.7% −2.3% +17.8% +25.3%
July 25, 2024 +12.7% +0.6% +18.8% +19.9%
April 25, 2024 −2.9% +0.6% −7.2% −4.3%
February 27, 2024 +12.0% +0.1% +8.3% +3.2%
October 25, 2023 −0.3% −2.6% −1.1% −9.1%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms . Generated November 3, 2026. Definitions in our methodology.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Reportable Segment Aggregation Before Other Operating $403M 98.1% ▲ 18.1%
Technology Products and Services $251M 62.4% ▲ 16.3%
Content Solutions $151M 37.6% ▲ 21.3%
All Other Segments $7.7M 1.9% ▼ 32.7%
Products and services
Line of business Revenue YoY
Services $218M ▲ 13.4%
Image Enhancement and Maintenance Services $218M ▲ 13.4%
Technology Sales $98.3M ▲ 12.0%
Technology Rentals $82.2M ▲ 31.4%
Finance Income $11.7M ▲ 21.1%

These categories overlap or exclude eliminations, so shares aren't shown.

Geography
Region Revenue Share YoY
United States $145M 35.3% ▲ 5.1%
Greater China $102M 24.9% ▲ 26.4%
Asia Excluding Greater China $66.6M 16.2% ▲ 15.5%
Western Europe $51.8M 12.6% ▲ 26.8%
Rest of World $24.1M 5.9% ▲ 45.4%
Canada $11.5M 2.8% ▲ 23.2%
Latin America $9M 2.2% ▼ 0.3%

From Imax Corp's 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$2B
Institutions reporting
255
Shares held vs prior quarter
▲ 5.4%
Positions opened / closed
41 / 36

Top buyers and sellers, Q2 2026: 131 institutions bought and 109 sold ; the biggest buyer was Congress Asset Management Co (+1.0M shares) and the biggest seller FMR LLC (−795K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Orbis Allan Gray Ltd $205M 5.1M 10.0% 0.0%
Nomura Asset Management International Inc. $117M 2.9M 5.7% ▼ 20.7%
Blackrock, Inc. $116M 2.9M 5.7% ▲ 10.9%
Westfield Capital Management Co LP $106M 2.7M 5.2% ▲ 13.5%
Congress Asset Management Co $101M 2.5M 4.9% ▲ 68.0%
Driehaus Capital Management LLC $93.3M 2.3M 4.6% ▲ 41.7%
FMR LLC $92.6M 2.3M 4.5% ▼ 25.5%
Ameriprise Financial Inc $70.6M 1.8M 3.4% ▲ 33.3%
Goldman Sachs Group Inc $66M 1.7M 3.2% ▲ 90.4%
Jpmorgan Chase & Co $58.8M 1.5M 2.9% ▲ 49.5%
Price T Rowe Associates Inc $57.7M 1.4M 2.8% ▲ 51.6%
Royce & Associates LP $53.5M 1.3M 2.6% ▲ 7.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Imax Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $69.7M 28 trades by 9 insiders · 65% under pre-set plans
Net ▼ $69.7M net selling
Insider Date Trade Shares Price Value
Lister Robert D Chief Legal Officer Sr Exec VP September 10, 2026 Sell 22,500 $51.58 $1.2M
Weissman Kenneth Ian Deputy GC, Corp. Sec. & CCO August 25, 2026 Sell 8,000 $54.54 $436,320
Welton Mark President IMAX Global Theatres August 25, 2026 Sell 30,000 $54.47 $1.6M
Fernandes Natasha Chief Financial Officer & EVP August 24, 2026 Sell 20,000 $54.63 $1.1M
Gelfond Richard L Chief Executive Officer August 20, 2026 Sell pre-set plan 100,000 $53.23 $5.3M
Pablo Calamera CTO & EVP August 20, 2026 Sell 15,000 $52.41 $786,150
Gelfond Richard L Chief Executive Officer August 19, 2026 Sell pre-set plan 205,504 $53.27 $10.9M
Gelfond Richard L Chief Executive Officer August 18, 2026 Sell pre-set plan 151,253 $51.00 $7.7M
Zlatar Jose Aleksandr SVP, Controller & PAO August 6, 2026 Sell 500 $49.90 $24,950
Gelfond Richard L Chief Executive Officer April 27, 2026 Sell pre-set plan 8,943 $37.33 $333,842
Gelfond Richard L Chief Executive Officer April 17, 2026 Sell pre-set plan 34,182 $37.06 $1.3M
Gelfond Richard L Chief Executive Officer April 16, 2026 Sell pre-set plan 41,737 $37.05 $1.5M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

No trades in Imax Corp disclosed in the last 12 months; 6 earlier trades on record.

  • Earl Blumenauer(D-OR 3):Sale (full), $1,001 - $15,000, traded June 17, 2022, filed July 6, 2022
  • Earl Blumenauer(D-OR 3):Sale (partial), $1,001 - $15,000, traded June 16, 2022, filed July 6, 2022
  • Earl Blumenauer(D-OR 3):Purchase, $1,001 - $15,000, traded February 11, 2022, filed March 7, 2022

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around October 22, 2026 estimated from the company's past filing pattern, not announced

  • July 23, 2026
  • April 30, 2026
  • February 25, 2026
  • October 23, 2025
  • July 24, 2025
  • April 23, 2025

Recent SEC filings

Data status

When each part of this page on Imax Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Imax Corp in brief

What does Imax Corp do?
Imax Corp is a US-listed company in the movies & entertainment industry. Its financial year ends in December.
What is Imax Corp's stock ticker?
Imax Corp trades under the ticker IMAX on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
Who are Imax Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Orbis Allan Gray Ltd, Nomura Asset Management International Inc. and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Are insiders buying or selling Imax Corp stock?
Over the last 12 months, Imax Corp's directors and officers reported 0 open-market purchases and 28 sales on Form 4. The insider trading page charts every trade.
When is Imax Corp's next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Imax Corp announces its own schedule.